Status:

UNKNOWN

Efficacy and Safety of Remimazolam Tosylate for Sedation in Gastroscopy

Lead Sponsor:

RenJi Hospital

Collaborating Sponsors:

Shanghai East Hospital

Affiliated Hospital of Jiaxing University

Conditions:

Hypoxia

Gastric Cancer

Eligibility:

All Genders

18-60 years

Phase:

NA

Brief Summary

Propofol is the most commonly used intravenous anesthetic for painless gastroscopy, but propofol significantly inhibits the respiratory and circulatory systems. Therefore, the incidence of intraoperat...

Eligibility Criteria

Inclusion

  • \- 1)18≤age≤60 years old, no gender limit; 2) Patients receiving routine gastroscopy diagnosis and treatment; 3) ASA score is I or II; 4) 18 kg/m2\<BMI\<28kg/m2; 5) It is estimated that the operation time of gastroscope will not exceed 30 minutes; 6) Clearly understand, voluntarily participate in the research, and be signed and informed consent.

Exclusion

  • Need to perform complicated endoscopic diagnosis and treatment techniques (such as cholangiopancreatography Surgery, endoscopic ultrasonography, endoscopic mucosal resection, endoscopic submucosa Stripping, oral endoscopic muscle dissection, etc.);
  • Patients who intend to undergo tracheal intubation;
  • It is judged to be difficult to manage the respiratory tract (modified Mallampati score is IV)patient;
  • Anemia or thrombocytopenia,( Hb\<90g/L, PLT\<80×109/L);
  • Diagnosed lung diseases (asthma, bronchitis, COPD, Pulmonary bullae,pulmonary embolism, pulmonary edema, lung cancer);
  • Liver and kidney disease;( AST and/or ALT≥2.5×ULN,TBIL≥1.5×ULN, blood creatinine is greater than the upper limit of normal);
  • There is a history of drug and/or alcohol abuse within 2 years before the beginning of the screening period.The average daily alcohol consumption exceeds 2 units of alcohol (1 unit = 360 mL beer Liquor or 45 mL liquor with 40% alcohol content or 150 mL grapes liqueur);
  • Hypertensive patients whose blood pressure has not been satisfactorily controlled by antihypertensive drugs(Sitting systolic blood pressure ≥160 mmHg during screening period, and/or diastolic pressure during screening period Pressure ≥100 mmHg);
  • Sitting systolic blood pressure ≤90 mmHg during the screening period;
  • Women who are pregnant or breastfeeding;
  • Benzodiazepines, opioids, propofol, lidoca Those who are allergic or contraindicated due to their drug components;
  • Participated in other drug clinical trials as subjects in the past 3 months;
  • The investigator believes that it is not appropriate to participate in this trial;
  • A well-diagnosed heart disease (heart failure, angina pectoris, myocardial infarction, heart rhythmabnormalities etc.).

Key Trial Info

Start Date :

March 2 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 1 2023

Estimated Enrollment :

1800 Patients enrolled

Trial Details

Trial ID

NCT04727034

Start Date

March 2 2021

End Date

August 1 2023

Last Update

October 12 2022

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Renji Hospital

Shanghai, Shanghai, China, China, 200127

2

Shanghai East Hospital

Shanghai, Shanghai, China, China, 200127

3

Affiliated Hospital of Jiaxing University

Jiaxing, China

4

The Second Affifiliated Hospital of Jiaxing University

Jiaxing, China